Procaterol
- Generic Name
- Procaterol
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C16H22N2O3
- CAS Number
- 72332-33-3
- Unique Ingredient Identifier
- X7I3EMM5K0
- Background
A long-acting beta-2-adrenergic receptor agonist. It is a potent bronchodilator that may be administered orally or by aerosol inhalation.
- Indication
For the treatment of asthma and chronic obstructive pulmonary disease (COPD).
- Associated Conditions
- Bronchial Asthma, Bronchospasm, Chronic Bronchitis, Emphysema
- Associated Therapies
- -
Bronchodilator Effect of Oral Doxofylline and Procaterol in Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2024-04-04
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- Thammasat University
- Target Recruit Count
- 20
- Registration Number
- NCT06346691
Effect of Oral Procaterol on Postinfectious Persistent Cough
- First Posted Date
- 2015-01-29
- Last Posted Date
- 2017-03-23
- Lead Sponsor
- Mahidol University
- Target Recruit Count
- 74
- Registration Number
- NCT02349919
- Locations
- 🇹🇭
Ramathibodi Hospital, Bangkok, Thailand
Bioavailability Study of SYN006, Pulmicort pMDI and Meptin Air in Healthy Adult.
Phase 1
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)Asthma
- Interventions
- First Posted Date
- 2014-06-17
- Last Posted Date
- 2015-06-03
- Lead Sponsor
- Intech Biopharm Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT02165046
- Locations
- 🇨🇳
Tri-Service General Hospital, Taipei, Taiwan
Comparative Study on the Efficacy and Safety of Procaterol Versus Salbutamol Given Via Metered Dose Inhaler With Spacer in the Management of Acute Asthma Attack in the Emergency Room
- First Posted Date
- 2010-03-24
- Last Posted Date
- 2010-03-24
- Lead Sponsor
- Otsuka Pharmaceutical, Inc., Philippines
- Target Recruit Count
- 96
- Registration Number
- NCT01091337
- Locations
- 🇵🇭
Philippine General Hospital, Manila, Philippines
Tiotropium + Procaterol vs Tiotropium + Placebo in COPD Patients
Phase 4
Terminated
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2006-11-01
- Last Posted Date
- 2009-12-17
- Lead Sponsor
- Otsuka Pharmaceutical, Inc., Philippines
- Target Recruit Count
- 50
- Registration Number
- NCT00394485
- Locations
- 🇵🇭
Philippine General Hospital, Manila, National Capital Region, Philippines
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath